This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genera Biosystems Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovations by Nick Vandegraaff in Respiratory Pathogen Detection
Introduction
Nick Vandegraaff is an accomplished inventor based in Victoria, Australia. He has made significant contributions to the field of respiratory pathogen detection through his innovative methods and compositions. His work focuses on enhancing the accuracy and efficiency of detecting various respiratory pathogens.
Latest Patents
Vandegraaff holds a patent for "Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads." This patent outlines methods for screening a multiplicity of respiratory pathogens by isolating nucleic acids from a sample. The process involves using solid phase amplification with specific forward and reverse primers, along with probes to generate amplicons. The method also incorporates bead sets that are homogeneous in size, which aids in determining the identity of the respiratory pathogen through the binding of particular amplicons to subsets of beads.
Career Highlights
Throughout his career, Nick Vandegraaff has been associated with Genera Biosystems Limited, where he has played a pivotal role in advancing diagnostic technologies. His expertise in molecular biology and diagnostics has positioned him as a key figure in the development of innovative solutions for pathogen detection.
Collaborations
Vandegraaff collaborates with various professionals in the field, including his coworker Karl Frederick Poetter. Their combined efforts contribute to the ongoing research and development of effective diagnostic methods.
Conclusion
Nick Vandegraaff's contributions to the field of respiratory pathogen detection exemplify the impact of innovative thinking in healthcare. His patented methods and compositions are paving the way for more accurate and efficient diagnostic tools.